Related Experiment Videos
Cell-mediated cytotoxicity against Sendai-virus-infected cells
Summary
Mice infected with Sendai virus develop thymus-derived cytotoxic lymphocytes that target virus-infected cells. This killer cell activity, crucial for antiviral immunity, peaks within a week and is H-2 restricted.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- Sendai virus, a parainfluenza virus type I, is known to elicit immune responses in mice.
- Cytotoxic lymphocytes play a critical role in recognizing and eliminating virus-infected cells.
- Understanding the kinetics and characteristics of cytotoxic responses is vital for vaccine development and immunotherapy.
Purpose of the Study:
- To characterize the cytotoxic lymphocytes generated in response to Sendai virus infection in mice.
- To investigate the kinetics, specificity, and regulatory mechanisms of this cell-mediated cytotoxicity.
- To explore the potential role of H-2 gene restriction in the cytotoxic interaction.
Main Methods:
- Mice were infected with Sendai virus.
- In vitro assays were performed to measure cytotoxic lymphocyte activity against Sendai virus-infected target cells.
- Antibody inhibition assays, H-2 compatibility studies, and analysis of antibody titers were conducted.
Main Results:
- Sendai virus infection induced thymus-derived cytotoxic lymphocytes specifically lysing virus-infected target cells.
- Cytotoxic activity peaked around day 7 post-infection and correlated inversely with haemagglutinating antibody levels.
- The cytotoxic response was H-2 gene restricted, with no lysis observed against tumor cells expressing viral antigens, and antibody-dependent cell-mediated cytolysis (ADCC) was absent.
Conclusions:
- Sendai virus infection induces a potent, H-2 restricted, thymus-derived cytotoxic lymphocyte response.
- This cellular immunity is distinct from antibody-dependent mechanisms and wanes as antibody levels rise.
- The findings provide insights into antiviral cellular immunity and H-2 restriction in cytotoxic T lymphocyte responses.